Neurological Manifestations Associated with SARS-CoV-2 Invasion of the Autonomous Nervous System

Abstract

BackgroundCOVID-19 patients can develop various central neurological disorders, including loss of smell and taste (anosmia and ageusia, respectively), ischemic injury (stroke), encephalopathy (delirium), and encephalitis [1,2], but also peripheral damages such as Guillain-Barré Syndrome (GBS) [3]. If the severity of respiratory failure remains the major determinant of the COVID-19 patient outcome, neurological disorders are also associated with increased mortality and morbidity [4]. In addition, to the role of COVID-19 severity markers, neurological disorders